
### [NCIT:C8856](http://purl.obolibrary.org/obo/NCIT_C8856)
**Label:** Stage III Diffuse Large B-Cell Lymphoma

**Subclasses:** [NCIT:C8878](http://purl.obolibrary.org/obo/NCIT_C8878) (Stage III Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C8137](http://purl.obolibrary.org/obo/NCIT_C8137) (Stage III Adult Immunoblastic Lymphoma), [NCIT:C8930](http://purl.obolibrary.org/obo/NCIT_C8930) (Stage III Centroblastic Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 53.75%
- [NCIT:C27970](http://purl.obolibrary.org/obo/NCIT_C27970) (Stage III) 52.27%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39679](http://purl.obolibrary.org/obo/NCIT_C39679) (Hallmark Cell))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39674](http://purl.obolibrary.org/obo/NCIT_C39674) (Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39657](http://purl.obolibrary.org/obo/NCIT_C39657) (Neoplastic T-Lymphocyte with Clear Cytoplasm))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39652](http://purl.obolibrary.org/obo/NCIT_C39652) (Proliferation of Follicular Dendritic Cells Present))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39651](http://purl.obolibrary.org/obo/NCIT_C39651) (Proliferation of High Endothelial Venules Present))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39646](http://purl.obolibrary.org/obo/NCIT_C39646) (Erythroderma))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39640](http://purl.obolibrary.org/obo/NCIT_C39640) (Mucinous Degeneration))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39629](http://purl.obolibrary.org/obo/NCIT_C39629) (CDKN2A Gene Inactivation))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39628](http://purl.obolibrary.org/obo/NCIT_C39628) (Single Cell Exocytosis))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39627](http://purl.obolibrary.org/obo/NCIT_C39627) (Pautrier Microabscess Present))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39626](http://purl.obolibrary.org/obo/NCIT_C39626) (Epidermotropic Lymphocytic Infiltrate))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39625](http://purl.obolibrary.org/obo/NCIT_C39625) (Extracutaneous Dissemination of Disease))) 37.63%


